Literature DB >> 7364953

A regional programme to collect plasma for preparation of human immunoglobulin anti-rabies.

R J Crawford, M Morgan, R Mitchell.   

Abstract

We identified over 100 recipients of rabies vaccine (human diploid cell vaccine) and recruited them as plasma donors. Some were plasmapheresed at static centres, others by mobile teams. The operation of these teams is described in detail. No plasma was sent to the Fractionation Centre until the date of vaccination had been checked. Assay results showed that the majority of plasma collected between four and 20 weeks after the second dose of vaccine contained 6 or more IU/ml.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7364953      PMCID: PMC1146017          DOI: 10.1136/jcp.33.2.180

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

Review 1.  Volume limitations of plasmapheresis.

Authors:  P Lundsgaard-Hansen
Journal:  Vox Sang       Date:  1977       Impact factor: 2.144

2.  Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum.

Authors:  M Bahmanyar; A Fayaz; S Nour-Salehi; M Mohammadi; H Koprowski
Journal:  JAMA       Date:  1976-12-13       Impact factor: 56.272

3.  Immunization against rabies with rabies immune globulin, human (RIGH) and a human diploid cell strain (HDCS) rabies vaccine.

Authors:  E K Kuwert; J Werner; I Marcus; V J Cabasso
Journal:  J Biol Stand       Date:  1978-07

4.  Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine.

Authors:  G S Turner
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.